Showing results (271-280 of 466) with videos related to

Sort By:
Pageof 47
Annals of the New York Academy of Sciences|January 1, 1991
Serum amyloid P in Alzheimer's disease. Implications for dysfunction of the blood-brain barrierR N Kalaria, T E Golde, M L Cohen, et al.
Chest|May 1, 1985
Echocardiographic findings after tricuspid valvectomyG Friedman, I Kronzon, J Nobile, et al.
The Journal of Pharmacy and Pharmacology|March 1, 1994
Comparative 5-HT2-receptor antagonist activity of amesergide and its active metabolite 4-hydroxyamesergide in rats and rabbitsM L Cohen, K D Kurz, R W Fuller, et al.
The American Journal of Physiology|August 1, 1989
A high density in vitro extracellular electrode array: description and implementationM L Cohen, R H Hoyt, J E Saffitz, et al.
Neuropharmacology|March 1, 1994
Zatosetron, a 5-HT3 receptor antagonist in a multicenter trial for acute migraineA S Chappell, J M Bay, G D Botzum, et al.
Physical Review Letters|August 11, 2001
Mechanical instability and ideal shear strength of transition metal carbides and nitridesS H Jhi, S G Louie, M L Cohen, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1993
Vascular serotonin 5-hydroxytryptamine2 receptor blockade by LY215840: lack of effect upon neointima formation in balloon-injured rat carotid arteriesR F Kauffman, J S Bean, W E Bloomquist, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1996
LY215840, a high-affinity 5-HT7 receptor ligand, blocks serotonin-induced relaxation in canine coronary arteryD J Cushing, J M Zgombick, D L Nelson, et al.
Pageof 47